Addition of Hycamtin Doesn’t Improve Outcomes in Newly Diagnosed Ovarian Cancer

Among women with newly diagnosed advanced ovarian cancer treatment with Hycamtin topotecan and cisplatin prior to standard chemotherapy increases side effects and does not improve progression-free survival These results were published in the Journal of th [...]

AMG 386 Shows Promise Against Recurrent Ovarian Cancer

In a Phase II clinical trial among women with recurrent ovarian cancer the investigational targeted therapy AMG 386 produced promising response rates when used in combination with paclitaxel These results were presented at the 35th European Society for Me [...]

Continued Chemotherapy in Advanced Ovarian Cancer

Continuing chemotherapy following initial treatment of advanced ovarian cancer may improve survival according to a study published in Cancer Ovarian cancer has the highest mortality rate of all gynecologic cancers It is the fifth leading cause of cancer d [...]

Farletuzumab Shows Promise in Relapsed Ovarian Cancer

According to the results of a Phase II clinical trial the investigational drug farletuzumab may have anticancer activity in the treatment of relapsed ovarian cancer when combined with chemotherapy These results were presented at a European cancer conferen [...]

Number of Obesity-related Cancers Is Growing

In 2008 excess body weight was responsible for over 124000 new cancer diagnoses in Europe These results were presented at a major European cancer conference Obesity is increasingly being recognized as a risk factor not only for cancer development but also [...]

Women Report Symptoms Prior to Diagnosis of Ovarian Cancer

Women commonly report symptoms to their primary care provider during the year before a diagnosis of ovarian cancer The results of this study which was conducted in the UK were published in the British Medical Journal Ovarian cancer has the highest mortali [...]

September Is National Ovarian Cancer Awareness Month

As the month of September brings ovarian cancer into focus its time to increase public understanding about the disease including its prevalence approaches to screening and prevention treatment options and resources that offer updated ovarian cancer inform [...]

Many High-risk Women Opt for Preventive Removal of Breasts and Ovaries

Many women who are considered to be at high risk for developing breast or ovarian cancer are choosing to undergo preventive mastectomy removal of breasts andor oophorectomy removal of ovaries in order to reduce their risk of developing the disease accordi [...]

Fertility Preservation Appears to Be Safe for Young Women with Early-stage Ovarian Cancer

Preservation of the non-cancerous ovary and the uterus appears to be safe for young women with Stage IA or IC ovarian cancer and allows women to preserve their fertility These results were published in Cancer Women who confront a cancer diagnosis at a you [...]

False-positive Results Are Common with Cancer Screening

The risk of obtaining a false-positive result from screening for prostate lung colorectal and ovarian cancer is high and becomes cumulatively higher with ongoing screeningafter 14 screening tests the cumulative risk of a false-positive is 604 for men and [...]